Orthofix Medical (NASDAQ:OFIX) (NASDAQ: OFIX) is a global medical device company focused on the design and development of innovative orthopedic and spinal solutions. The company’s core business is divided into two segments: spine and orthopedics. In the spine segment, Orthofix offers a range of titanium implants, biologics and portable bone growth stimulation devices designed to support spinal fusion, deformity correction and minimally invasive procedures. Its orthopedic segment encompasses products for fracture fixation, external fixation systems, trauma care and sports medicine, providing surgeons with implantable devices and instruments for complex bone reconstruction and healing.
Orthofix’s product portfolio includes strut systems, bone growth stimulators, interbody fusion devices and fixation hardware that address various indications such as degenerative disc disease, spinal deformities, non-unions and long-bone fractures. The company’s bone growth stimulation devices utilize pulsed electromagnetic field (PEMF) technology to accelerate the body’s natural healing processes, while its spinal implants are engineered to offer structural support and promote new bone formation at the fusion site. Orthofix continually invests in research and development to expand its offerings, optimize surgical techniques and enhance patient outcomes.
Founded in 1980 and headquartered in Lewisville, Texas, Orthofix has grown through organic expansion and strategic acquisitions. The company maintains its own sales force and distribution capabilities in key markets across North America, Europe, Latin America, Asia Pacific and other regions, serving hospitals, ambulatory surgical centers and specialty orthopedic clinics. Orthofix’s global footprint enables it to tailor product training, clinical support and customer service to meet regional needs and regulatory requirements.
Under the leadership of President and Chief Executive Officer Michael Musso, Orthofix emphasizes a collaborative culture, clinical education and evidence-based practices. The company partners with leading surgeons, research institutions and patient advocacy groups to drive innovation, publish clinical data and raise awareness of its technologies. Orthofix remains committed to advancing musculoskeletal care by delivering solutions that address unmet clinical needs and improve quality of life for patients worldwide.
